Ozempic 3.0? This drug causes the greatest weight loss — by far
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective for obese adults who do not have diabetes.
The weight loss drug revolution is shrinking America's waistline
Losing weight in the new year won't take the same shape as it did in the past. Why it matters: The emergence of groundbreaking new weight-loss drugs is transforming how Americans shed pounds. Nearly 18 million Americans are expected to be taking versions of GLP-1 drugs by 2029,
America’s love-hate relationship with the new weight-loss drugs
Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls significantly when they learn that the weight might come back when the meds are stopped.
23 celebrities who've opened up about taking Ozempic or weight-loss drugs
As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.
Lilly asks to join lawsuit over compounded versions of its weight-loss drugs
Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug Administration over the agency's decision that Lilly's blockbuster weight-loss and diabetes drugs are no longer in short supply.
As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles,
How use of weight-loss drugs such as Ozempic has grown in Washington state
Axios Visuals The emergence of groundbreaking weight-loss drugs is transforming how Americans shed pounds, including in Washington state. The big picture: Nearly 18 million Americans are expected to be taking versions of GLP-1 drugs by 2029,
Should Medicaid Pay for Ozempic and Other Weight-Loss Drugs?
With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.
Medscape20d
A New Weight Loss Drug With No Side Effects? Yes…So Far
Another big one is muscle loss. A new ... weight loss,” Gerhart-Hines said. He explained that GLP-1 agonists don’t work quite as well for weight loss in people with diabetes because the ...
The Washington Post29d
Age and the new weight-loss drugs
Are you wondering whether you’re a candidate for one of the newer weight-loss drugs, semaglutide (Wegovy ... Center at Weill Cornell Medicine in New York City. This helps control blood sugar.
Professor Tim Spector issues weight loss jab food warning
Professor Tim Spector and his Zoe co-founder Jonathan Wolf have issued advice for those looking to change their diets in the ...
Yahoo Finance18d
Novo Nordisk's New Weight-Loss Drug Lags Behind Eli Lilly's Zepbound
Novo Nordisk (NYSE:NVO)'s new weight loss drug CagriSema missed the company's target of reducing at least 25% body weight of the Phase 3 trials' participants. CagriSema only showed an ...
Ozempic and Similar Drugs May Offer Health Benefits Beyond Weight Loss, Including Reduced Alcohol Cravings
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
New York Post26d
1 in 6 people plan to skip their weight-loss drugs over the holidays so they can eat more
About 12% of US users of drugs like Ozempic and Wegovy ... medical content lead at Levity, an online weight-loss management service that conducted the new poll of 1,000 US and UK residents.
MarketWatch18d
Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
The U.S.-listed shares of Novo Nordisk A.S. were plunging toward their worst day in decades on Friday after the results from a late-stage trial showed that the Danish company’s new weight-loss ...